ENDLOS-TURBO PUT - AMGEN | Market Closed - Deutsche Boerse AG 03:35:00 2024-07-11 pm EDT | ||
| 3.65 EUR | -12.26% |
|
| Current month | -26.26% | ||
| 1 month | -38.24% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24-07-11 | 3.65 | -12.26% |
| 24-07-10 | 4.16 | -10.73% |
| 24-07-09 | 4.66 | -6.05% |
| 24-07-08 | 4.96 | -1.00% |
| 24-07-05 | 5.01 | -3.28% |
Delayed Quote Deutsche Boerse AG
Last update July 11, 2024 at 03:35 pm EDT
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | AMGEN INC. |
| Issuer | DZ BANK |
| WKN | DJ4SFL |
| ISIN | DE000DJ4SFL5 |
| Date issued | 2023-08-10 |
| Strike | 364.6 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 9.66 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 11 € |
|---|---|
| Lowest since issue | 3.53 € |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
325.1
USD
Average target price
316.1
USD
Spread / Average Target
-2.75%
- Stock Market
- Certificates
- Certificat
